HKSE - Delayed Quote HKD

INNOVATIVE PHAR (0399.HK)

Compare
0.153
-0.002
(-1.29%)
At close: 3:57:50 PM GMT+8

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Mr. Rong Tang Executive Director 548k -- 1967
Mr. Yuan Xing Gao Executive Director 1.36M -- 1955

INNOVATIVE PHAR

On Hong Commercial Building
20/F Unit No. 2002 145 Hennessy Road
Wan Chai
Hong Kong
852 2598 6818 https://www.ipb.asia
Industry: 
Specialty Retail
Full Time Employees: 
20

Description

Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trade of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the research, development, and commercialization of oral insulin products; distribution of bio-industrial products; healthcare management; and provision of genetic testing services, as well as securities investment. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Corporate Governance

INNOVATIVE PHAR’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events